Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push into obesity drugs.
The Therapeutic Goods Administration said Moderna would be able to be used as a booster regardless of what COVID-19 vaccine ...
With a 28-day clock counting down between shots, Gretchen Ciavaglia searched desperately for more than a week to get her 91-year-old father-in-law an appointment for his second COVID-19 vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results